Related Experiment Video

Updated: Jun 22, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.4K

Protein Kinases - High Yield Targets for Cancer and Dementia Drug Discovery

Rachna Shroff1, Edward J Goetzl2

  • 1Department of Medicine, University of Arizona College of Medicine, Tucson.

The American Journal of Medicine
|June 26, 2024
PubMed

Insights

Protein kinase inhibitors are crucial for treating cancers and neurodegenerative diseases. New therapies improve effectiveness and reduce side effects, enhancing treatment outcomes.

Area of Science:

  • Biochemistry and Molecular Biology
  • Oncology
  • Neuroscience

Background:

  • Cellular protein kinases regulate essential cellular functions.
  • Dysregulation of protein kinases contributes to cancers and neurodegenerative diseases like Alzheimer's.
  • Over 80 small-molecule protein kinase inhibitors are FDA-approved for treating these conditions.

Purpose of the Study:

  • To review the role of protein kinases in disease.
  • To highlight the success of protein kinase inhibitors in clinical practice.
  • To discuss advancements in designing novel inhibitors and therapies.

Main Methods:

  • Literature review of protein kinase inhibitors.
  • Analysis of FDA-approved drugs for cancer and neurodegenerative diseases.
  • Examination of molecular mechanisms underlying drug resistance and side effects.

Main Results:

  • Protein kinase inhibitors are effective treatments for various cancers and neurodegenerative diseases.
  • Recent therapeutic advancements have mitigated resistance and side effects.
  • Improved understanding of molecular mechanisms drives the development of next-generation inhibitors.

Conclusions:

  • Protein kinase inhibitors represent a cornerstone in treating major diseases.
  • Continued research into molecular mechanisms will enhance therapeutic strategies.
  • Future developments promise greater efficacy and improved patient outcomes for cancer and Alzheimer's disease.
Keywords:
Alzheimer's disease treatmentCancer treatmentKinase protein family

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K